Showing results (551-560 of 709) with videos related to

Sort By:
Pageof 71
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2002
Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient miceEdward E S Nieuwenhuis, Markus F Neurath, Nadia Corazza, et al.
BMC Cancer|March 24, 2012
Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significanceMichael Heise, Anja Lautem, Johanna Knapstein, et al.
Alimentary Pharmacology & Therapeutics|June 5, 2018
Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patientsC Labenz, J S Baron, G Toenges, et al.
United European Gastroenterology Journal|March 28, 2020
Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patientsSophia Heinrich, Martin Sprinzl, Irene Schmidtmann, et al.
The Oncologist|October 3, 2022
Ramucirumab for Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha Fetoprotein Following Non-Sorafenib Systemic Therapy: An Expansion Cohort of REACH-2Richard S Finn, Thomas Yau, Chih-Hung Hsu, et al.
Blood|March 15, 1995
p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemiasHartmut Döhner, Konstanze Fischer, Martin Bentz, et al.
Diagnostics (Basel, Switzerland)|April 14, 2026
Adding Estimates of Central Venous Pressure Boosts the Performance of Non-Invasive Assessment of the Portosystemic Gradient Prior to TIPS ImplantationFabian Stoehr, Maximilian Moos, Lukas Müller, et al.
Liver Cancer|May 7, 2025
Depth and Duration of Response Are Associated with Survival in Patients with Unresectable Hepatocellular Carcinoma: Exploratory Analyses of IMbrave150Masatoshi Kudo, Tatsuya Yamashita, Richard S Finn, et al.
European Journal of Cancer (Oxford, England : 1990)|May 13, 2011
An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancerM Moehler, A Mueller, J T Hartmann, et al.
European Journal of Internal Medicine|June 11, 2015
New onset of diabetes after transplantation is associated with improved patient survival after liver transplantation due to confounding factorF Darstein, C König, M Hoppe-Lotichius, et al.
Pageof 71